Skip to content
Clinical Trials – home
Sponsor

Electra Therapeutics Inc.

United States 201 Haskins Way Floor 5th, 94080-6215, United States

About the sponsor

Electra Therapeutics Inc. is focused on clinical research in secondary hemophagocytic lymphohistiocytosis (sHLH), with attention to the severe inflammatory and immune dysregulation seen in this rare condition. Its active trial program includes participants with macrophage hemophagocytic lymphohistiocytosis (mHLH) linked to lymphoma, reflecting interest in complex hematologic and immune-mediated disease settings.

  • Immune hyperinflammation
  • Hemophagocytic syndromes
  • Hematologic malignancy-associated inflammation

The sponsor’s research activity in this area is centered on clinical needs where immune activation and underlying cancer triggers intersect, particularly within specialized hematology and oncology care environments.

About Specializations

Electra Therapeutics Inc. runs clinical trials in conditions such as Haemophagocytic lymphohistiocytosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:ELA026
  • Sponsor:Electra Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.